QbD
Continuous improvement in the pharmaceutical industry
October 12 by Pharmaceuticals & Biotechnology EditorWhat is CI, and why should you attempt to implement it? We take a brief overview of the topic.
A Roadmap from Batch to Continuous Manufacturing
January 22 by Pharmaceuticals & Biotechnology EditorContinuous manufacturing is continuing to gain momentum in pharmaceutical and biotech industries, with a demand for greater quality assurance and product consistency. Driven by the potential to incr...
Developing Healthcare Apps in 2015: Market Insights
December 08 by Pharmaceuticals & Biotechnology EditorHealthcare apps will revolutionise healthcare diagnosis, research and provision in this decade and the promise they hold is only beginning to be unlocked. To help you get a snapshot of this exciting...
Facing Cross-Industry Challenges in the Food and Pharma Industries
March 06 by Pharmaceuticals & Biotechnology EditorFood companies are becoming pharma companies. Pharma-foods, the intersection between food and pharmaceuticals, represents an area of growing opportunities for the food sector. Peter J. Boogaard exam...
Gawayne Mahboubian-Jones on International Standards to Support the Application of Process Analytical Technology
January 13 by Andrea CharlesIn this interview Gawayne Mahboubian-Jones, Manager of Quality by Design for Philip Morris International, shares his views on international standards to support the application of Process Analytical...
Process Analytical Technology & Quality by Design Overview 2014
December 14 by Pharmaceuticals & Biotechnology EditorFor the past 11 years, Pharma IQ’s PAT & Quality By Design conference has been bringing you the latest case studies to help show you the benefits of PAT and QbD and how to effectively implement Qb...
Legal Flash: 8 Regulations set to impact the Pharma & Biotech Industry in 2013
April 15 by Niamh MadiganPharma IQ has put together a list of 8 regulations and guidelines that look set to impact different divisions of the biotech and pharma industry in 2013. ONE: Good Distributio...
3 Key Trends in PAT / QbD Implementation
April 11 by Peter BoogaardPeter Boogaard, Founder of Industrial Lab Automation and Director at Vialis AG recently gave a workshop at the recent 10th anniversary Pat & Quality by Design Conference which recently took plac...
QbD:Regulatory and Scientific Possibilities and Challenges
February 22 by Niamh MadiganGert Ragnarsson, Director of the Swedish Medical Projects Agency, discusses the biggest milestones in QbD over the last decade, including: The establishment of harmonised guidelines Th...
Implementing QbD Initiatives
February 20 by Peter BoogaardContinual improvement drives quality and starts at the top Leadership, outstanding processes, and culture are the ingredients for making companies successful. When Philip Crosby published his fir...
Informatics Engine Drives Pharma Development toward Quality by Design
January 18 by Pharmaceuticals & Biotechnology EditorThe pharmaceutical industry is looking at is looking for more holistic approaches to improve the process of bring products to the market. Adopting these approaches can accelerate product develo...
The 7 Deadly Sins of Quality Assurance and Quality Control
November 11 by Pharmaceuticals & Biotechnology EditorThe Seven Sins of QA and QC are those transgressions which are detrimental to quality and profitability. You will probably commit some of them every day. We asked the global pharmaceutical commu...